Seven Cornell faculty members have been elected fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. This year's fellows, 564 in all, will be honored at a virtual event Feb. 19.
As many as one in four children in Flint, Michigan – far above the national average – may have experienced elevated blood lead levels after the city’s 2014 water crisis, finds new research by Jerel Ezell, assistant professor in the Africana Studies and Research Center.
By mapping all the protein interactions of a dementia-linked protein in the brain called Tau, a team of Weill Cornell Medicine investigators has created a road map for identifying potential new treatment targets for Alzheimer’s disease and related dementia.
Cornell startups Ava Labs have new key partnerships with Deloitte and Mastercard, while university startup companies SwiftScale Biologics and Novomer have been acquired.
New nanophotonic tweezers developed by Cornell researchers can stretch and unzip DNA molecules as well as disrupt and map protein-DNA interactions, paving the way for commercial availability.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
The Division of Nutritional Sciences and partner RTI International won a five-year, $23 million award to coordinate research for the NIH’s Nutrition for Precision Health study.
